상품명칭 |
바스타딘 10 |
별명 |
바스타딘 10; 5,16,21,32-테트라브로모-4,20,29-트리하이드록시-2,18-다이옥사-10,27-디아자펜타시클로(28.2.2.2(14,17).1(3,7).1(19,23))옥타트리아콘타-3,5,7(38),14,16,19,21,23(35),30,32,33,36-도데카엔-11,12,25,26-테트론 12,25-디옥심; 바스타딘-10; 2,18-Dioxa-10,27-diazapentacyclo(28.2.2.2(14,17).1(3,7).1(19,23))octatriaconta-3,5,7(38),14,16,19,21,23(35),30,32,33,36-dodecaene-11,12,25,26-tetrone, 5,16,21,32-tetrabromo-4,20,29-trihydroxy-, 12,25-dioxime; (29S)-5,16,21,32-테트라브로모-4,20,29-트리하이드록시-12,25-비스(하이드록시이미노)-2,18-디옥사-10,27-디아자펜타시클로[28.2.2.214,17.1 3,7.1 19,23]옥타트리아콘타-1(32),3(38),4,6,14,16,19(35),20,22,30,33,36-도데카엔-11,26-디온 |
영문 이름 |
bastadin 10;Bastadin 10; 5,16,21,32-Tetrabromo-4,20,29-trihydroxy-2,18-dioxa-10,27-diazapentacyclo(28.2.2.2(14,17).1(3,7).1(19,23))octatriaconta-3,5,7(38),14,16,19,21,23(35),30,32,33,36-dodecaene-11,12,25,26-tetrone 12,25-dioxime; Bastadin-10; 2,18-Dioxa-10,27-diazapentacyclo(28.2.2.2(14,17).1(3,7).1(19,23))octatriaconta-3,5,7(38),14,16,19,21,23(35),30,32,33,36-dodecaene-11,12,25,26-tetrone, 5,16,21,32-tetrabromo-4,20,29-trihydroxy-, 12,25-dioxime; (29S)-5,16,21,32-tetrabromo-4,20,29-trihydroxy-12,25-bis(hydroxyimino)-2,18-dioxa-10,27-diazapentacyclo[28.2.2.214,17.13,7.119,23]octatriaconta-1(32),3(38),4,6,14,16,19(35),20,22,30,33,36-dodecaene-11,26-dione |
분자식 |
C34H28Br4N4O9 |
분자량 |
956.2235 |
InChI |
InChI=1/C34H28Br4N4O9/c35-20-7-16-1-3-27(20)50-30-13-18(9-23(38)32(30)45)11-25(42-49)34(47)40-15-26(43)19-2-4-28(21(36)14-19)51-29-12-17(8-22(37)31(29)44)5-6-39-33(46)24(10-16)41-48/h1-4,7-9,12-14,26,43-45,48-49H,5-6,10-11,15H2,(H,39,46)(H,40,47)/b41-24-,42-25+/t26-/m1/s1 |
cas번호 |
127687-08-5 |
분자 구조 |
|
밀도 |
1.917g/cm3 |
굴절 지수 |
1.723 |
위험성 표시 |
|
리스크 규칙 |
|
보안 규칙 |
|
|